SANARA MEDTECH INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-37.6M | $-9.7M | $-4.3M | $-7.9M | $-7.9M | $-4.4M | $-2.8M | $-600.6K |
| Depreciation & Amortization | $3.9M | $4.9M | $3.7M | $2.4M | $597.0K | $291.4K | $120.0K | $83.9K |
| Depreciation | $175.6K | $190.9K | $456.1K | $407.8K | $220.6K | $67.8K | $29.9K | — |
| Amortization | $2.5M | $2.6M | $3.2M | $2.0M | $376.4K | $223.5K | $90.0K | — |
| Stock-Based Compensation | $5.2M | $4.4M | $3.4M | $2.7M | $2.7M | $1.4M | $0 | — |
| Net Cash from Operating Activities | $6.8M | $-23.8K | $-3.2M | $-5.6M | $-4.8M | $-4.0M | $-2.2M | $277.1K |
| Investing Activities | ||||||||
| Capital Expenditures | $4.6M | $205.8K | $265.2K | $147.0K | $171.9K | $544.4K | $182.8K | $8.5K |
| Business Acquisitions | — | — | $9.9M | $2.5M | — | — | — | — |
| Net Cash from Investing Activities | $-15.0M | $-6.6M | $-10.2M | $-3.5M | $-5.3M | $-2.7M | $-1.2M | $-8.5K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $8.9M | $17.4M | $9.6M | $-627.3K | $28.3M | $622.3K | $9.8M | $0 |
| Net Change in Cash | $700.6K | $10.7M | $-3.8M | $-9.7M | $18.2M | $-6.2M | $6.4M | — |
| Free Cash Flow | $2.2M | $-229.6K | $-3.5M | $-5.7M | $-5.0M | $-4.6M | $-2.4M | $268.7K |